Rankings
▼
Calendar
OMER
Omeros Corporation
$821M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30M
+547.9% YoY
Gross Profit
$30M
99.1% margin
Operating Income
-$11M
-37.2% margin
Net Income
-$16M
-55.1% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
+11.6%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$91M
Total Liabilities
$231M
Stockholders' Equity
-$140M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30M
$5M
+547.9%
Gross Profit
$30M
$5M
+546.9%
Operating Income
-$11M
-$35M
+68.7%
Net Income
-$16M
-$39M
+58.3%
← FY 2019
All Quarters
Q4 2019 →
OMER Q3 2019 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena